Andreas Krämer

10PUBLICATIONS
57CO-AUTHORS
Characterisation of biological macromoleculesIndustrial molecular engineering of nucleic acids and proteinsProteins and peptidesCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 04, 2026
Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137.

|Dec 04, 2025
Targeting bacterial kinases as a strategy to counteract antibiotic resistance.

Vanessa Buffa, Julien Kowalewski, Guoman Qi

|Jun 13, 2025
Crystallographic fragment screening reveals ligand hotspots in TRIM21 PRY-SPRY domain.

Yeojin Kim, Aleksandar Lučić, Christopher Lenz

|Jun 04, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2.

Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo

|Feb 16, 2025
LOPAC library screening identifies suramin as a TRIM21 binder with a unique binding mode revealed by crystal structure.

Yeojin Kim, Stefan Knapp, Andreas Krämer

|Sep 14, 2024
Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2.

Han Wee Ong, Xuan Yang, Jeffery L Smith

Pageof 2

Frequent Collaborators

8 joint publications

Stefan Knapp

4 joint publications

Thomas Hanke

3 joint publications

Martin P Schwalm

2 joint publications

Lewis Elson